Is Teyro Labs Private Limited FDA approved?

Teyro Labs Private Limited holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Teyro Labs Private Limited's drugs manufactured?

The FDA register lists Kanchipuram District. Registered operations: analytical testing, finished drug manufacture, packaging.

What drugs does Teyro Labs Private Limited make?

8 products are listed under Teyro Labs Private Limited in the openFDA NDC Directory, most often as injection, solution; injection, powder, lyophilized, for solution; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Are any Teyro Labs Private Limited products in shortage?

4 presentations are currently listed in the FDA drug shortage database under Teyro Labs Private Limited, covering Carboplatin Injection.

Teyro Labs Private Limited

Data as of 1 Oct 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 8
Live patents: 0
Shortage listings: 4
Countries: 1
Base: India

Authorisation

Registered operations

Analytical testing1Finished drug manufacture1Packaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Teyro Labs Private Limited	Plot No. A-9/1, SIPCOT Industrial Growth Centre Oragadam, Kanchipuram District, Tamil Nadu 601301, India (IND)	Analytical testing, Finished drug manufacture, Packaging	3021389808854377573

Alert

Drug shortage listings

Drug	Presentation	Status	Availability	Posted / updated
Carboplatin InjectionOncology	Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)	Current	Unavailable	28 Apr 20231 Oct 2026
Carboplatin InjectionOncology	Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)	Current	Unavailable	28 Apr 20231 Oct 2026
Carboplatin InjectionOncology	Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)	Current	Unavailable	28 Apr 20231 Oct 2026
Carboplatin InjectionOncology	Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)	Current	Unavailable	28 Apr 20231 Oct 2026

Catalogue

Drug listings by form and route

8 active NDC listings: 8 human prescription drug. By marketing category: ANDA 8.

Dosage form	NDCs
injection, solution	4
injection, powder, lyophilized, for solution	2
tablet, film coated	2

Route	NDCs
intravenous	6
oral	2

Labeller name on the listing	NDCs
teyro labs private limited	8

Catalogue

Marketed products

Brand	Generic name	Form / route	NDC
CARBOPLATIN	CARBOPLATIN	injection, solution, intravenous	82511-003ANDA
CARBOPLATIN	CARBOPLATIN	injection, solution, intravenous	82511-004ANDA
CARBOPLATIN	CARBOPLATIN	injection, solution, intravenous	82511-005ANDA
CARBOPLATIN	CARBOPLATIN	injection, solution, intravenous	82511-006ANDA
Capecitabine	capecitabine	tablet, film coated, oral	82511-001ANDA
Capecitabine	capecitabine	tablet, film coated, oral	82511-002ANDA
Gemcitabine hydrochloride	Gemcitabine hydrochloride	injection, powder, lyophilized, for solution, intravenous	82511-008ANDA
Gemcitabine hydrochloride	Gemcitabine hydrochloride	injection, powder, lyophilized, for solution, intravenous	82511-009ANDA

Compare

Comparable companies in India

Zydus Pharmaceuticals USA Inc.1 site · 626 NDC
Somerset Therapeutics Private Limited1 site · 187 NDC
Bionpharma Inc.1 site · 181 NDC
Jubilant Biosys Limited1 site · 94 NDC
Xiromed LLC1 site · 94 NDC
CAPLIN STERILES LIMITED1 site · 88 NDC
Maithri Drugs Private Limited1 site · 80 NDC
MSN Pharmachem Private Limited1 site · 54 NDC
UMEDICA LABORATORIES PRIVATE LIMITED1 site · 52 NDC
APOTHECON PHARMACEUTICALS PRIVATE LIMITED1 site · 38 NDC

Enquiry

Common questions

Is Teyro Labs Private Limited FDA approved?: Teyro Labs Private Limited holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Teyro Labs Private Limited's drugs manufactured?: The FDA register lists Kanchipuram District. Registered operations: analytical testing, finished drug manufacture, packaging.
What drugs does Teyro Labs Private Limited make?: 8 products are listed under Teyro Labs Private Limited in the openFDA NDC Directory, most often as injection, solution; injection, powder, lyophilized, for solution; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Are any Teyro Labs Private Limited products in shortage?: 4 presentations are currently listed in the FDA drug shortage database under Teyro Labs Private Limited, covering Carboplatin Injection.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.